134 related articles for article (PubMed ID: 32680608)
1. Cardiac allograft vasculopathy and secondary outcomes of hepatitis C-positive donor hearts at 1 year after transplantation.
Madan S; Patel SR; Jorde UP
J Heart Lung Transplant; 2020 Nov; 39(11):1318-1321. PubMed ID: 32680608
[No Abstract] [Full Text] [Related]
2. A Reason to be Positive: Early Cardiac Allograft Vasculopathy and Acute Rejection in Recipients of HCV+ Donor Hearts.
Dichiacchio L; Higgins AR
J Card Fail; 2024 May; 30(5):701-702. PubMed ID: 38218346
[No Abstract] [Full Text] [Related]
3. Impact of Traumatically Brain-Injured Donors on Outcomes After Heart Transplantation.
Suarez-Pierre A; Crawford TC; Zhou X; Lui C; Fraser CD; Etchill E; Sharma K; Higgins RS; Whitman GJ; Kilic A; Choi CW
J Surg Res; 2019 Aug; 240():40-47. PubMed ID: 30909064
[TBL] [Abstract][Full Text] [Related]
4. Survival, graft function, and incidence of allograft vasculopathy in heart transplant patients receiving adverse risk profile donor hearts.
Berg K; Clemmensen TS; Tram EM; Koefoed-Nielsen P; Ilkjaer LB; Poulsen SH; Eiskjaer H
Clin Transplant; 2018 Aug; 32(8):e13343. PubMed ID: 29974979
[TBL] [Abstract][Full Text] [Related]
5. The curious phenomenon of early cardiac allograft rejection with hepatitis C‒infected donor heart transplants.
Woolley AE; Singh SK
J Heart Lung Transplant; 2020 Nov; 39(11):1208-1209. PubMed ID: 32978057
[No Abstract] [Full Text] [Related]
6. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
[TBL] [Abstract][Full Text] [Related]
7. Effects of Older Donor Age and Cold Ischemic Time on Long-Term Outcomes of Heart Transplantation.
Reich HJ; Kobashigawa JA; Aintablian T; Ramzy D; Kittleson MM; Esmailian F
Tex Heart Inst J; 2018 Feb; 45(1):17-22. PubMed ID: 29556146
[TBL] [Abstract][Full Text] [Related]
8. Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts.
Balam S; Buchtler S; Winter F; Schmidbauer K; Neumayer S; Talke Y; Renner K; Geissler EK; Mack M
Front Immunol; 2021; 12():816509. PubMed ID: 35126373
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
[TBL] [Abstract][Full Text] [Related]
10. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.
Haji SA; Starling RC; Avery RK; Mawhorter S; Tuzcu EM; Schoenhagen P; Cook DJ; Ratliff NB; McCarthy PM; Young JB; Yamani MH
J Heart Lung Transplant; 2004 Mar; 23(3):277-83. PubMed ID: 15019636
[TBL] [Abstract][Full Text] [Related]
11. Cocaine use in organ donors and long-term outcome after heart transplantation: An International Society for Heart and Lung Transplantation registry analysis.
Vieira JL; Cherikh WS; Lindblad K; Stehlik J; Mehra MR
J Heart Lung Transplant; 2020 Dec; 39(12):1341-1350. PubMed ID: 32950382
[TBL] [Abstract][Full Text] [Related]
12. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
[TBL] [Abstract][Full Text] [Related]
13. Cardiac allograft vasculopathy: a donor or recipient induced pathology?
van den Hoogen P; Huibers MM; Sluijter JP; de Weger RA
J Cardiovasc Transl Res; 2015 Mar; 8(2):106-16. PubMed ID: 25652948
[TBL] [Abstract][Full Text] [Related]
14. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
[TBL] [Abstract][Full Text] [Related]
15. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
[TBL] [Abstract][Full Text] [Related]
16. Elevated Heart Rate Following Heart Transplantation Is Associated With Increased Graft Vasculopathy and Mortality.
Liebo M; Newman J; Joshi A; Lowes BD; Peled-Potashnik Y; Basha HI; Zolty R; Um JY; McGee E; Heroux A; Raichlin E
J Card Fail; 2019 Apr; 25(4):249-256. PubMed ID: 30685400
[TBL] [Abstract][Full Text] [Related]
17. Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation network.
Fluschnik N; Geelhoed B; Becher PM; Schrage B; Brunner FJ; Knappe D; Bernhardt AM; Blankenberg S; Kobashigawa J; Reichenspurner H; Schnabel RB; Magnussen C
Int J Cardiol; 2021 May; 331():57-62. PubMed ID: 33571561
[TBL] [Abstract][Full Text] [Related]
18. Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient.
Yamani MH; Cook DJ; Tuzcu EM; Paul P; Ratliff NB; Yu Y; Hobbs R; Rincon G; Bott-Silverman C; Smedira N; Young JB; Starling RC
J Heart Lung Transplant; 2005 Aug; 24(8):1014-8. PubMed ID: 16102435
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
[TBL] [Abstract][Full Text] [Related]
20. The impact of donor sex on heart transplantation outcomes-a study of over 60,000 patients in the United States.
Zhu Y; Shudo Y; Lingala B; Joseph Woo Y
J Heart Lung Transplant; 2021 Aug; 40(8):814-821. PubMed ID: 34083118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
